World TAVR Market to See Healthy Growth, Predicts Koncept Analytics in Its Report Now Available at MarketPublishers.com
03 Apr 2017 • by Natalie Aster
LONDON – Today, transcatheter aortic valve replacement (TAVR) is viewed as a novel progressive technology in the field of medical science, which is used as an alternative to conventional surgical aortic valve replacement, it is used as an option for patients who are under certain risks from the surgical procedure.
In the years ahead, the marketplace is expected to demonstrate healthy growth owing to a slew of positive factors, including escalating elderly population number, rising expenditures on healthcare, surging obesity incidence along with ongoing world’s economic development. Moreover, increasing incidence of aortic stenosis and mushrooming demand for less invasive surgery procedures will also add to the market growth and open new lucrative opportunities for the market players.
Still, the TAVR marketplace is likely to face certain growth challenges, for instance, business cycle fluctuations, strict regulations, high prices of TAVR devices and risks associated with the TAVR method.
Edwards Lifesciences, Boston Scientific, Medtronic and St. Jude Medical are among the dominant companies active in the world’s TAVR market.
Insightful research report “Global Transcatheter Aortic Valve Replacement (TAVR) Market: Industry Analysis & Outlook (2017-2021)” drawn up by Koncept Analytics provides a deep analysis of the market, focusing on the USA, APAC and European markets. The study traces light on the market dynamics, examines top trends, highlights the market growth drivers, challenges and restraints. The main TAVR market participants are profiled in this report together with important data on the competitive environment and pressures in the market. Future outlook for the market up till 2021 are also at hand here.
Other comprehensive research reports by Koncept Analytics are available at its page at MarketPublishers.com.